glp 1 receptor agonists weight loss How GLP-1 Evolved from Diabetes to Treatments GLP-1 Receptor Agonists as Treatments
Description
The preference for SGLT2i is due to more robust evidence regarding renal outcomes
None of these effects require a functioning beta cell which is exactly why researchers started exploring them in T1D
Through its various mechanisms of action, tirzepatide is a perfect candidate drug for both the treatment and prevention of diabetic cardiomyopathy
To view digital features for this article go to Introduction Obesity (defined as a body mass index [BMI] 30 kg/m 2 in adults [1]) is a major health concern in the USA [2] and is associated with multiple complications, including cardiovascular disease, type 2 diabetes, and osteoarthritis [3,4,5,6,7,8]
